Rammelburg Castle as a potential residence for Elon Musk - invitation to visit
3.2.2025 13:27:34 CET | news aktuell GmbH | Press release
Peter Karl Jugl refers to the Bild article from January 30, titled “This Could Be Elon Musk’s New European Headquarters”.
Rammelburg, Germany, January 31, 2025 – Jugl, Managing Director of Deutsche Baukultur Dienstleistungs GmbH, which owns Rammelburg Castle, is offering the visionary entrepreneur Elon Musk the historic property as a weekend retreat, holiday residence, or company headquarters. As a great admirer of Musk’s innovative projects and his commitment to the future of humanity, Jugl would even be willing to gift him the castle.
“I warmly invite Elon Musk to visit Rammelburg Castle in person and experience its unique atmosphere firsthand,” says Jugl.
Jugl is also the Managing Director of Thekenberge Entwicklungsgesellschaft mbH, which owns the world’s largest bunker complex, Komplexlager 12, also known by the codename Malachite. The bunker is located just an hour from the castle and could also be of interest to Musk.
With this extraordinary gesture, Peter Karl Jugl wants to offer Elon Musk an exclusive and inspiring retreat in Germany and would be delighted to welcome him to his castle.
Press contact:
Peter Karl Jugl
Markkleeberg, Germany
Phone: +49 170 984 85 71
Reporting location: Rammelburg, Germany
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Compax MVNE continues to support Airalo’s eSIM platform2.3.2026 14:46:10 CET | Press release
Compax, a leading solution provider in the MVNO and telco space, will continue to support Airalo, the world’s first and largest eSIM platform.
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release
Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.
Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press release
The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence.
Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:53:34 CET | Press release
(Munich, February 24th, 2026) Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P). ESA’s Meteoroid And Space debris Terrestrial Environment Reference (MASTER) model provides a description of the space environment around Earth, supporting satellite designers, operators and others with risk assessments. Currently, there exists a significant temporal and spatial knowledge gap for observations of space debris with sizes smaller than the detection limit of ground-based sensors. Vyoma's Flamingo-1 satellite is ideally positioned to generate the image data ESA is seeking. Flying “in-situ” at an altitude of 510 km, Flamingo-1's instrument can monitor large volumes of space at once. This sensor detects objects at long and short distances and captures small and fast objects reliably, im
Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press release
Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom